BellBrook

Transcreener CD73 FP Assay

CHF 0.00
In stock
BBL-3026-1K1000 assaysCHF 1'234.00
BBL-3026-10K10000 assaysCHF 6'497.00
BBL-3026-100K10 x 10000 assaysINQ
More Information
Product Details
Synonyms Ecto-5'-nucleotidase
Product Type Kit
Properties
Application Set Compound Screening
Crossreactivity All
Quantity

1000 assays/384wells (BBL-3026-1K)

10000 assays/384wells (BBL-3026-10K)

10 x 10000 assays/384wells (BBL-3026-100K)

Note: The exact number of assays depends on enzyme reaction conditions.

Range Excellent data quality (Z’ ≥ 0.7) and signal (≥85 mP polarization shift) at ADO ranges between 0.3 μM and 3 μM.
Detection Type Fluorescent polarization
Kit Contains

ADP2 Antibody, ADP Alexa Fluor® 633 Tracer, Coupling Enzyme, ATP, AMP, ADO.

Note:  The plates are not included, please see manual for material not provided but necessary for assay.

Other Product Data

Click here for Complete Information from the Original Manufacturer
Our product description may differ slightly from the original manufacturers product datasheet.


Assay Features

Detection of unlabeled Adenosine
Easy to use, homogenous, one-step format
Robust Assay Z’ > 0.7 under initial velocity conditions
Far-red fluorescent readout minimize compound interference
A safe, non-radioactive method

Declaration Manufactured by BellBrook Labs.
Shipping and Handling
Shipping DRY ICE
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
Manual Download PDF
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

The Transcreener® HTS Assay platform overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by utilizing a single set of assay reagents that detect an invariant product. The generic nature of the Transcreener® HTS Assay platform eliminates delays involved in assay development for new HTS targets, and greatly simplifies compound and inhibitor profiling across multiple target families. Transcreener assays have been validated with major HTS instruments to determine the optimal filters and settings for maximal assay performance. Application notes with all important details are available.

The Transcreener CD73 Assay measures adenosine (ADO) produced by ecto-5'-nucleotidase (also known as 5'-nucleotidase, NT5E, Cluster of Differentiation 73 or CD73). By measuring the production of ADO researchers can effectively determine the activity of the enzyme. The assay provides a powerful tool to screen entire compound libraries for CD73 modulators to help find new therapeutics for diseases such as cancer.

The assay uses a coupling enzyme that uses ADO produced by CD73 to produce the products AMP and ADP. ADP can then be measured using the trusted Transcreener ADP² Assay components. The kit comes complete with all the detection reagents required to measure activity. CD73 enzyme is not included in the inhibitor screening assay kit. 

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.